🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chosa Oncology AB (FRA:W5L)
Germany flag Germany · Delayed Price · Currency is EUR
0.0392
+0.0062 (18.79%)
At close: Nov 18, 2026

Chosa Oncology AB Company Description

Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden and USA.

It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient’s response to platinum-based chemotherapy; and LiPlaCis, a liposomal formulation of cisplatin, enabling delivery of chemotherapy agent directly to tumor sites.

The company was formerly known as Chosa ApS. Chosa Oncology AB was incorporated in 2015 and is based in Malmö, Sweden.

Chosa Oncology AB
CountrySweden
Founded2015
IndustryBiological Products, Except Diagnostic Substances
Employees2
CEOPeter Jensen

Contact Details

Address:
Kungsgatan 6
Malmö, 211 49
Sweden
Phone45 2 16 08 922
Websitechosaoncology.com

Stock Details

Ticker SymbolW5L
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0007784319
SIC Code2836

Key Executives

NamePosition
Peter JensenChief Executive Officer
Gerton JonssonChief Financial Officer
Ulla BuhlChief Operating Officer